Lucie Bourgoin

1.2k total citations
16 papers, 974 citations indexed

About

Lucie Bourgoin is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Lucie Bourgoin has authored 16 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Epidemiology and 3 papers in Hepatology. Recurrent topics in Lucie Bourgoin's work include Liver Disease Diagnosis and Treatment (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Neuroscience and Neuropharmacology Research (2 papers). Lucie Bourgoin is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Neuroscience and Neuropharmacology Research (2 papers). Lucie Bourgoin collaborates with scholars based in Switzerland, United Kingdom and Italy. Lucie Bourgoin's co-authors include Michelangelo Foti, Marion Peyrou, Emmanuel Biver, Serge Ferrari, Eleni Douni, Nicolas Bonnet, Aurélie Caillon, Nicolas Deblon, Christelle Veyrat‐Durebex and Françoise Rohner‐Jeanrenaud and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Hepatology.

In The Last Decade

Lucie Bourgoin

16 papers receiving 963 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucie Bourgoin Switzerland 13 417 198 189 183 155 16 974
John-Olov Jansson Sweden 14 416 1.0× 336 1.7× 158 0.8× 18 0.1× 240 1.5× 19 1.5k
S. Vincent Wu United States 23 453 1.1× 188 0.9× 116 0.6× 108 0.6× 144 0.9× 51 1.4k
Pierre Corvol France 9 306 0.7× 95 0.5× 73 0.4× 114 0.6× 45 0.3× 9 1.8k
Ingegerd Söderström Sweden 18 201 0.5× 225 1.1× 185 1.0× 31 0.2× 31 0.2× 26 1.1k
María Gómez‐Serrano Spain 19 423 1.0× 175 0.9× 146 0.8× 66 0.4× 40 0.3× 39 935
Jack C. Sipe United States 19 306 0.7× 159 0.8× 110 0.6× 15 0.1× 87 0.6× 31 1.8k
Xuequn Chen China 15 215 0.5× 135 0.7× 43 0.2× 24 0.1× 147 0.9× 25 688
Takeshi Nigawara Japan 19 168 0.4× 111 0.6× 82 0.4× 77 0.4× 83 0.5× 55 1.2k
Nina Suda United States 5 683 1.6× 299 1.5× 157 0.8× 30 0.2× 216 1.4× 7 1.4k
Sigri Beckers Belgium 19 380 0.9× 273 1.4× 220 1.2× 5 0.0× 274 1.8× 47 1.2k

Countries citing papers authored by Lucie Bourgoin

Since Specialization
Citations

This map shows the geographic impact of Lucie Bourgoin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucie Bourgoin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucie Bourgoin more than expected).

Fields of papers citing papers by Lucie Bourgoin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucie Bourgoin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucie Bourgoin. The network helps show where Lucie Bourgoin may publish in the future.

Co-authorship network of co-authors of Lucie Bourgoin

This figure shows the co-authorship network connecting the top 25 collaborators of Lucie Bourgoin. A scholar is included among the top collaborators of Lucie Bourgoin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucie Bourgoin. Lucie Bourgoin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gjorgjieva, Monika, Nicolas Calo, Cyril Sobolewski, et al.. (2024). Hepatic IR and IGF1R signaling govern distinct metabolic and carcinogenic processes upon PTEN deficiency in the liver. JHEP Reports. 7(4). 101305–101305. 4 indexed citations
2.
Bonnet, Nicolas, Lucie Bourgoin, Emmanuel Biver, Eleni Douni, & Serge Ferrari. (2019). RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass. Journal of Clinical Investigation. 129(8). 3214–3223. 220 indexed citations
3.
Martín‐García, Elena, Lucie Bourgoin, Adeline Cathala, et al.. (2015). Differential Control of Cocaine Self-Administration by GABAergic and Glutamatergic CB1 Cannabinoid Receptors. Neuropsychopharmacology. 41(9). 2192–2205. 37 indexed citations
4.
Reiss, David J., Ondine Walter, Lucie Bourgoin, Brigitte Kieffer, & Abdel‐Mouttalib Ouagazzal. (2014). New automated procedure to assess context recognition memory in mice. Psychopharmacology. 231(22). 4337–4347. 6 indexed citations
5.
Peyrou, Marion, Lucie Bourgoin, Anne-Laure Poher, et al.. (2014). Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice. Journal of Hepatology. 62(2). 421–429. 56 indexed citations
6.
Rappa, Francesca, Azzura Greco, Christine Podrini, et al.. (2013). Correction: Immunopositivity for Histone MacroH2A1 Isoforms Marks Steatosis-Associated Hepatocellular Carcinoma. PLoS ONE. 8(3). 18 indexed citations
7.
Rappa, Francesca, Azzura Greco, Christine Podrini, et al.. (2013). Immunopositivity for Histone MacroH2A1 Isoforms Marks Steatosis-Associated Hepatocellular Carcinoma. PLoS ONE. 8(1). e54458–e54458. 58 indexed citations
8.
Peyrou, Marion, Sophie Clément, Christiane Maier, et al.. (2013). PTEN protein phosphatase activity regulates hepatitis C virus secretion through modulation of cholesterol metabolism. Journal of Hepatology. 59(3). 420–426. 29 indexed citations
9.
Zimmermann, Céline, Christopher R. Cederroth, Lucie Bourgoin, Michelangelo Foti, & Serge Nef. (2012). Prevention of Diabetes in db/db Mice by Dietary Soy Is Independent of Isoflavone Levels. Endocrinology. 153(11). 5200–5211. 26 indexed citations
10.
Peyrou, Marion, Pierluigi Ramadori, Lucie Bourgoin, & Michelangelo Foti. (2012). PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs. PPAR Research. 2012. 1–16. 52 indexed citations
11.
Peyrou, Marion, Lucie Bourgoin, David M. Suter, et al.. (2011). 810 DOWNREGULATION OF PTEN AND IRS1 BY HCV 3A CORE PROTEIN TRIGGERS STEATOSIS IN HEPATOCYTES. Journal of Hepatology. 54. S325–S325. 1 indexed citations
12.
Deblon, Nicolas, Christelle Veyrat‐Durebex, Lucie Bourgoin, et al.. (2011). Mechanisms of the Anti-Obesity Effects of Oxytocin in Diet-Induced Obese Rats. PLoS ONE. 6(9). e25565–e25565. 216 indexed citations
13.
Deblon, Nicolas, Lucie Bourgoin, Christelle Veyrat‐Durebex, et al.. (2011). Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats. British Journal of Pharmacology. 165(7). 2325–2340. 132 indexed citations
14.
Clément, Sophie, Marion Peyrou, Lucie Bourgoin, et al.. (2011). Down-regulation of phosphatase and tensin homolog by hepatitis C virus core 3a in hepatocytes triggers the formation of large lipid droplets. Hepatology. 54(1). 38–49. 57 indexed citations
15.
Peyrou, Marion, Lucie Bourgoin, & Michelangelo Foti. (2010). PTEN in Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis and Cancer. Digestive Diseases. 28(1). 236–246. 46 indexed citations
16.
Fournier, Margot, Marion Peyrou, Lucie Bourgoin, et al.. (2010). CD4 dimerization requires two cysteines in the cytoplasmic domain of the molecule and occurs in microdomains distinct from lipid rafts. Molecular Immunology. 47(16). 2594–2603. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026